• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

泛素-蛋白酶体途径与肌肉萎缩。

Ubiquitin-Proteasome Pathway and Muscle Atrophy.

机构信息

Biochemistry Department, Delta University for Science and Technology, Gamasaa, Egypt.

出版信息

Adv Exp Med Biol. 2018;1088:235-248. doi: 10.1007/978-981-13-1435-3_10.

DOI:10.1007/978-981-13-1435-3_10
PMID:30390254
Abstract

Many systemic diseases are featured by muscle atrophy. Cellular proteins are modified by covalent attachment to a small protein known as ubiquitin (Ub) through ubiquitination. This ubiquitination process serves as signal for protein turnover that leads to rapid muscle mass lack. This process is carried out through an enzymatic cascade, which includes three groups of enzymes termed ubiquitin E1 (activating enzyme), ubiquitin E2 (conjugating enzyme), and ubiquitin E3 (ligase). There are several ways of ubiquitin conjugation driving to ubiquitination of specific proteins through ubiquitin-proteasome system (UPS). A lot of UPS genes stated to be included in skeletal muscle atrophy. These genes do their effects by modifying different processes which affect muscle mass including myofibrillar protein degradation, myogenesis inhibition, and even modulation of autophagy as well as upstream regulatory pathways.

摘要

许多系统性疾病的特征是肌肉萎缩。细胞蛋白通过与一种称为泛素(Ub)的小蛋白的共价连接进行修饰。这种泛素化过程作为导致肌肉质量迅速丧失的蛋白质周转的信号。该过程通过酶级联反应进行,该反应包括三个酶组,称为泛素 E1(激活酶)、泛素 E2(连接酶)和泛素 E3(连接酶)。有几种泛素连接的方式通过泛素-蛋白酶体系统(UPS)导致特定蛋白质的泛素化。许多 UPS 基因被认为包含在骨骼肌萎缩中。这些基因通过修饰影响肌肉质量的不同过程发挥作用,包括肌原纤维蛋白降解、成肌抑制,甚至自噬的调节以及上游调节途径。

相似文献

1
Ubiquitin-Proteasome Pathway and Muscle Atrophy.泛素-蛋白酶体途径与肌肉萎缩。
Adv Exp Med Biol. 2018;1088:235-248. doi: 10.1007/978-981-13-1435-3_10.
2
A critical discussion on the relationship between E3 ubiquitin ligases, protein degradation, and skeletal muscle wasting: it's not that simple.关于 E3 泛素连接酶、蛋白质降解和骨骼肌减少之间关系的批判性讨论:事情并非如此简单。
Am J Physiol Cell Physiol. 2023 Dec 1;325(6):C1567-C1582. doi: 10.1152/ajpcell.00457.2023. Epub 2023 Nov 13.
3
The ubiquitin-proteasome system and skeletal muscle wasting.泛素-蛋白酶体系统与骨骼肌萎缩
Essays Biochem. 2005;41:173-86. doi: 10.1042/EB0410173.
4
Implication of altered ubiquitin-proteasome system and ER stress in the muscle atrophy of diabetic rats.泛素 - 蛋白酶体系统改变及内质网应激在糖尿病大鼠肌肉萎缩中的作用
Arch Biochem Biophys. 2018 Feb 1;639:16-25. doi: 10.1016/j.abb.2017.12.015. Epub 2017 Dec 24.
5
The ubiquitin proteasome system in atrophying skeletal muscle: roles and regulation.萎缩骨骼肌中的泛素蛋白酶体系统:作用与调控
Am J Physiol Cell Physiol. 2016 Sep 1;311(3):C392-403. doi: 10.1152/ajpcell.00125.2016. Epub 2016 Aug 10.
6
Mapping the interactome of HPV E6 and E7 oncoproteins with the ubiquitin-proteasome system.描绘 HPV E6 和 E7 癌蛋白与泛素-蛋白酶体系统的相互作用组。
FEBS J. 2017 Oct;284(19):3171-3201. doi: 10.1111/febs.14193. Epub 2017 Aug 29.
7
Role of the ubiquitin proteasome system in hematologic malignancies.泛素蛋白酶体系统在血液系统恶性肿瘤中的作用。
Immunol Rev. 2015 Jan;263(1):224-39. doi: 10.1111/imr.12236.
8
Molecular signaling pathways regulating muscle proteolysis during atrophy.萎缩过程中调节肌肉蛋白水解的分子信号通路。
Curr Opin Clin Nutr Metab Care. 2005 May;8(3):271-5. doi: 10.1097/01.mco.0000165005.01331.45.
9
Small Molecular Weight Soybean Protein-Derived Peptides Nutriment Attenuates Rat Burn Injury-Induced Muscle Atrophy by Modulation of Ubiquitin-Proteasome System and Autophagy Signaling Pathway.小分子大豆蛋白衍生肽营养通过调节泛素-蛋白酶体系统和自噬信号通路来减轻大鼠烧伤诱导的肌肉萎缩。
J Agric Food Chem. 2018 Mar 21;66(11):2724-2734. doi: 10.1021/acs.jafc.7b05387. Epub 2018 Mar 8.
10
Control of ubiquitination in skeletal muscle wasting.骨骼肌萎缩中泛素化的调控
Int J Biochem Cell Biol. 2005 Oct;37(10):2075-87. doi: 10.1016/j.biocel.2004.11.011. Epub 2004 Dec 15.

引用本文的文献

1
Protective Efficacy of Postbiotic beLP-K in a Dexamethasone-Induced Sarcopenia Model.后生元beLP-K在地塞米松诱导的肌肉减少症模型中的保护作用
Int J Mol Sci. 2025 Aug 3;26(15):7504. doi: 10.3390/ijms26157504.
2
Intramuscular CMT-167 Tumors Produce a Mild Cachexia Phenotype in C57BL/6J Mice.肌肉注射CMT-167肿瘤在C57BL/6J小鼠中产生轻度恶病质表型。
JCSM Commun. 2025 Jan-Jun;8(1). doi: 10.1002/rco2.117. Epub 2025 Feb 6.
3
Cisplatin-Induced Muscle Wasting and Atrophy: Molecular Mechanism and Potential Therapeutic Interventions.
顺铂诱导的肌肉消耗与萎缩:分子机制及潜在治疗干预措施
J Cachexia Sarcopenia Muscle. 2025 Jun;16(3):e13817. doi: 10.1002/jcsm.13817.
4
The Loss of HJV Aggravates Muscle Atrophy by Promoting the Activation of the TβRII/Smad3 Pathway.HJV的缺失通过促进TβRII/Smad3信号通路的激活加重肌肉萎缩。
Int J Mol Sci. 2025 Feb 26;26(5):2016. doi: 10.3390/ijms26052016.
5
Combating chronic kidney disease-associated cachexia: A literature review of recent therapeutic approaches.对抗慢性肾脏病相关性恶病质:近期治疗方法的文献综述
BMC Nephrol. 2025 Mar 11;26(1):133. doi: 10.1186/s12882-025-04057-8.
6
Fermented red ginseng extract improves sarcopenia-related muscle atrophy in old mice through regulation of muscle protein metabolism.发酵红参提取物通过调节肌肉蛋白质代谢改善老年小鼠的少肌症相关肌肉萎缩。
Food Sci Biotechnol. 2024 Sep 23;34(3):793-802. doi: 10.1007/s10068-024-01702-0. eCollection 2025 Feb.
7
Transcriptome sequencing analysis reveals the molecular mechanism of sepsis-induced muscle atrophy.转录组测序分析揭示了脓毒症诱导的肌肉萎缩的分子机制。
J Thorac Dis. 2024 Nov 30;16(11):7751-7770. doi: 10.21037/jtd-24-1665. Epub 2024 Nov 29.
8
Treatment advances of sepsis‑induced myopathy (Review).脓毒症诱导性肌病的治疗进展(综述)
Biomed Rep. 2024 Nov 25;22(2):19. doi: 10.3892/br.2024.1897. eCollection 2025 Feb.
9
Astragaloside IV Improves Muscle Atrophy by Modulating the Activity of UPS and ALP via Suppressing Oxidative Stress and Inflammation in Denervated Mice.黄芪甲苷通过抑制失神经支配小鼠的氧化应激和炎症反应,调节UPS和ALP的活性来改善肌肉萎缩。
Mol Neurobiol. 2025 Apr;62(4):4689-4704. doi: 10.1007/s12035-024-04590-x. Epub 2024 Oct 31.
10
Targeting MuRF1 to Combat Skeletal Muscle Wasting in Cardiac Cachexia: Mechanisms and Therapeutic Prospects.靶向 MuRF1 防治心脏恶病质骨骼肌丢失:机制与治疗前景。
Med Sci Monit. 2024 Oct 22;30:e945211. doi: 10.12659/MSM.945211.